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Divergent selection has created rat phenotypes of high- and low-capacity runners (HCR and
LCR, respectively) that have differences in aerobic capacity and correlated traits such as adipos-
ity. We analyzed visceral adipose tissue of HCR and LCR using label-free high-definition MS
(elevated energy) profiling. The running capacity of HCR was ninefold greater than LCR. Pro-
teome profiling encompassed 448 proteins and detected 30 significant (p<0.05; false discovery
rate <10%, calculated using q-values) differences. Approximately half of the proteins analyzed
were of mitochondrial origin, but there were no significant differences in the abundance of
proteins involved in aerobic metabolism. Instead, adipose tissue of LCR rats exhibited greater
abundances of proteins associated with adipogenesis (e.g. cathepsin D), ER stress (e.g. 78 kDa
glucose response protein), and inflammation (e.g. Ig gamma-2B chain C region). Whereas the
abundance antioxidant enzymes such as superoxide dismutase [Cu-Zn] was greater in HCR
tissue. Putative adipokines were also detected, in particular protein S100-B, was 431% more
abundant in LCR adipose tissue. These findings reveal low running capacity is associated with
a pathological profile in visceral adipose tissue proteome despite no detectable differences in
mitochondrial protein abundance.
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1 Introduction
Worldwide the levels of obesity have almost doubled since
1980 and approximately 3.4 million adults die each year as a
result of being overweight or obese. In particular, abdominal
obesity is associated with a heightened risk of cardiovascular
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disease and type 2 diabetes mellitus (T2DM) and is a cardi-
nal feature of the metabolic syndrome. Indeed, almost half
of the worldwide diabetes burden, and one-quarter of the is-
chemic heart disease burden is attributable to overweight and
obesity.
Diet-inducedmodels of obesity are common as are targeted
and spontaneous genetic models such as the Zucker fatty rat
[1]. However, in addition to diet and energy intake, physical
activity and energy expenditure also impact on whole body
energy balance and composition. We have used divergent ar-
tificial selection on running capacity to create high-capacity
runner (HCR) and low-capacity runner (LCR) rats that have
profound differences in running capacity and exhibit numer-
ous correlated traits relevant to human disease. While HCR
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animals are relatively lean and have a low disease risk profile,
LCR rats are overweight [2], hypertensive [3], insulin resistant
[4], and have a significantly shorter life expectancy [5]. More-
over, in response to a high fat diet, LCR are more prone to
exacerbation of this insulin-resistant condition whereas HCR
are protected despite their low levels of habitual activity and
relatively greater calorific intake [2].
Biochemical assessment of carcass composition [6] reveals
the percentage body fat of adult LCR (36%) is more than
double that (16%) of HCR. More specifically, the greater
adiposity of LCR is due to the increased masses of retroperi-
toneal, omental, and periretroproductive fat pads [7], and en-
largement of such visceral adipose depots, in particular, is
intimately associated with cardiometabolic disease risk [8]. In
striated muscle, the weight of evidence from our HCR/LCR
model points to mechanistic links between low respiratory
capacity and mitochondrial dysfunction associated with de-
fects in contractile function and substrate metabolism. In
contrast, recent examination of visceral adipose tissue of
LCR/HCR [9] reported nomajor differences inmitochondrial
enzyme content despite overt differences in running capacity
and adipose tissue mass. It seems unlikely artificial selec-
tion has left adipose tissue unaffected but as yet the nature
of the effect in adipose tissue is unknown at the molecular
level.
Herein, we use label-free proteomic profiling as a non-
targeted approach to discover differences between HCR
and LCR. This approach is designed to highlight candidate
biomarkers or direct future research regarding the greater
adiposity and enhanced rate of adipogenesis of LCR in re-
sponse to environmental stresses such as a high-fat diet. We
used a quadrupole time-of-flight (Q-TOF) mass spectrom-
eter operated in data-independent acquisition (DIA) mode,
which affords more detailed detection of peak profiles and
improves measurement precision compared to classic data-
dependent acquisitions [10]. Relative expression data gener-
ated by this instrumentwas analyzedusing the “Hi-3”method
wherein label-free quantitation is performed on the summed
ion counts from the three most intense peptides from each
protein normalized to an exogenous protein spiked in to each
sample [11]. This approach affords robust differential anal-
ysis based on the normalized abundance of proteins and
was performed on biological replicates of HCR and LCR
animals.
2 Materials and methods
2.1 Animal model and tissue collection
The inception of HCR-LCR strains from a founder popula-
tion of genetically heterogeneous N:NIH rats has been de-
scribed in detail [12]. Animals were housed (two per cage)
in accordance with the University of Michigan Committee
guidelines on the use and care of animals. Environmental
conditions were 20–21°C, 40–50% relative humidity with a
12-h light (0600–1800) and dark cycle, and food and water
were available ad libitum.
Rats from generation 26 of selection were used in the cur-
rent work. Consistent with our standard selection procedures
[12], HCR and LCR animals were phenotyped by their maxi-
mum running capacity at 10 weeks of age. Briefly, endurance
trials were performed on an inclined (15 degrees) motorized
treadmill (Columbus Instruments, OH) on five consecutive
days. The treadmill velocity began at 10 m/min and was in-
creased by 1 m/min every 2 min until exhaustion. Exhaus-
tion was operationally defined as the third time a rat could no
longer keep pacewith the speed of the treadmill and remained
on the shock grid for 2 s. At this point, the total distance (m)
run was recorded. The single best distance of the five trials
was considered as the performance indicator most closely as-
sociated with the heritable component of endurance running
capacity. Other than the aforementioned phenotyping trials,
rats used in the current report were sedentary and did not
perform exercise training. Therefore, the difference in run-
ning capacity between HCR and LCR is primarily an innate
response to selection.
Two weeks after completing the exercise trials male HCR
and LCR rats (n = 6, of each) were weighed and anesthetized
using sodiumpentobarbital (60mg/kg bodymass). Retroperi-
toneal fat pads were surgically excised, then freeze-clamped
in liquid nitrogen, and stored at −80C as part of our routine
tissue archiving procedure.
2.2 Sample preparation
Visceral fat samples (100 mg) were homogenized on ice
in ten volumes of 1% (v/v) Triton x-100, 250 mM sucrose,
100mMNaCl, 5 mM EDTA, 25mMTris, pH 7.4, at 4°C, con-
taining complete protease inhibitor (Roche Diagnostics). Af-
ter centrifugation at 12 000 × g, 4°C for 45-min supernatants
were decanted and an aliquot containing 100 g protein pre-
cipitated in five volumes of acetone for 1 h at −20°C. Pellets
were resuspended in 1% (w/v) SDS and incubated at 90°C
for 30 min before being washed twice through 5 kDa molec-
ular weight cut-off spin columns (Vivaspin; Sigma-Aldrich,
Gillingham, UK) using 0.1% (w/v) Rapigest SF (Waters; Mil-
ford, MA, USA) in 50 mM ammonium bicarbonate (500 L
per wash). Protein suspensions were concentrated to 50 L,
then incubated at 80°C for 15 min. DTT was added (final
concentration 1 mM) and incubated at 60°C for 15 min fol-
lowed by incubation while protected from light in the pres-
ence of 5mM iodoacetamide at 4°C. Sequencing grade trypsin
(Promega; Madison, WI, USA) was added at a protein ratio of
1:50 and digestion allowed to proceed at 37°C overnight. Di-
gestion was terminated by the addition of 2 L concentrated
TFA and peptide solutions were cleared by centrifugation at
13 000 × g for 5 min. Samples were diluted 1:1 with a tryp-
tic digest of yeast alcohol dehydrogenase (100 fmol/ L) to
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enable the amount of each identified protein to be quantified,
as described previously using a “Hi 3” methodology [11].
2.3 High-definition MS (elevated energy)
Tryptic peptide mixtures were analyzed by nanoscale
ultra-performance liquid chromatography (nanoACQUITY,
Waters) and online nano electrospray ionisation (ESI)
ion-mobility mass spectrometry (HDMSE; SYNAPT G2-S,
Waters, Manchester, UK). Samples (200 ng tryptic peptides)
were loaded in aqueous 0.1% (v/v) formic acid via a Symmetry
C18 5 m, 5 mm x 300 m precolumn (Waters). Separation
was conducted at 35°C through a HSS T3 C18 3 m, 15 cm ×
75 m analytical reverse phase column (Waters). Peptides
were eluted using a gradient rising to 40% ACN 0.1% (v/v)
formic acid over 90 min at a flow rate of 300 nL/min.
Additionally, a Lockmass reference (100 fmol/ L Glu-1-
fibrinopeptide B) was delivered to the NanoLockSpray source
of the mass spectrometer at a flow rate of 500 nL/ min, and
was sampled at 60-s intervals.
For all measurements, the mass spectrometer was oper-
ated in a data-independent positive ESI mode at a resolution
of >20 000 FWHM. Prior to analysis, the time-of-flight an-
alyzer was calibrated with an NaCsI mixture from m/z 50
to 1990. HDMSE analyses were conducted within the Tri-
wave ion guide. Accumulated ions were separated according
to their drift time characteristics in the N2 gas-filled mobility
cell prior to CID alternating between low (4 eV) and elevated
(14-40 eV) collision energies at a scan speed of 0.9 s per func-
tion over 50–2000 m/z.
Each biological sample was analyzed in replicate. Analyt-
ical data were LockMass corrected postacquisition using the
doubly charged monoisotopic ion of the Glu-1-fibrinopeptide
B. Charge reduction and deconvolution of potential parent-
fragment correlation was achieved in the first instance by
means of retention anddrift time alignment, as described pre-
viously [13]. Briefly, protein identifications and quantification
information were extracted using the dedicated algorithms
employed in ProteinLynx GlobalSERVER (PLGS) v2.5 (Wa-
ters). Peak lists were searched against the Uniprot database
(18 January 2012) restricted to ‘Rattus’ (7500 entries). The
enzyme specificity was trypsin allowing one missed cleav-
age, carbamidomethyl modification of cysteine (fixed), oxida-
tion of methionine (variable), and the parent and fragment
ion ppm error automatically calculated from the data. Decoy
databases were employed to allow the calculation of iden-
tification error rates and scoring of the database searches
was refined by correlation of physicochemical properties of
fragmented peptides from theoretical and experimental data.
Data were uploaded and checked in PRIDE converter and
inspector [14]. Functional enrichment testing was performed
using the Database for Annotation, Visualisation and Inte-
grated Discovery (DAVID v6.7; [15, 16]) and protein interac-
tions were investigated using the search tool for interacting
genes/proteins (STRING v9.1; [17]).
3 Results
3.1 Exercise capacity of HCR and LCR rats
Proteomeprofilingwasperformedon retroperitoneal fat from
male HCR and LCR of generation 26. The average running
capacity of HCR (1926 ± 160 m) was  ninefold greater (p
<0.0001) than LCR (216 ± 34 m), whereas the average body
weight of LCR (329 ± 23 g) was 50% greater (p <0.0001)
than HCR (242 ± 13 g). Fat pad masses were not recorded
during the tissue archiving procedure, but as a point of ref-
erence, Table 1 in Demarco et al. [7] reports the masses of
retroperitoneal, perireproductive, and omental fat depots in
male and female HCR and LCR rats from generation 27 at
30 weeks of age. Consistent with a number of earlier stud-
ies (e.g. [2,18–21]), Demarco et al., [7] reports retroperitoneal
mass in male LCR (11.14 ± 1.2 g) was more than double (p
<0.005) that of HCR (4.2 ± 0.5 g).
3.2 HDMSE analysis of visceral fat proteins
HDMSE analysis of replicate adipose tissue homogenates
from six HCR and six LCR rats produced a nonredundant list
of 1023 proteins at a false-positive rate <4%. This number is
close to the 1493 proteins identified in Xie et al. [22] using LC-
MS/MS analysis of 20 molecular weight fractions (i.e. GeLC-
MS/MS) of adipocytes isolated from human subcutaneous
adipose tissue. Adachi et al. [23] reports a more comprehen-
sive catalog (a total of 3287 proteins) of adipocyte proteins,
which was achieved by fractionating 3T3-L1 adipocytes to nu-
clear, mitochondrial, membrane, and cytosolic components
followed by GeLC-MS/MS to culminate in a total of 45 frac-
tions per sample. MS data of technical replicates of eachHCR
and LCR sample are available in the PRoteomics IDEntifica-
tion (PRIDE) database (www.ebi.ac.uk/pride/). Supporting
Information Table 1 reports the identity and relative abun-
dance of a subset of 448 proteins that were replicated in at
least four out of the six samples from each group and were
used in differential statistical analysis of the HCR and LCR
groups. Supporting Information Table 1 also includes data
extracted from Adachi et al., [23] reporting homologs of pro-
teins identified in the mouse adipocyte proteome.
Based on the estimated protein abundance on-column, the
dynamic range of the current analysis spanned three orders
of magnitude. Among the most abundant (amount on col-
umn) proteins identified were serum albumin (75 pg), car-
bonic anhydrase (28 pg), and fatty acid ethyl ester synthase
(26 pg), which is a major lipase in white adipose tissue.
The least abundant (amount on column) proteins meeting
the inclusion criteria for statistical analysis were galectin-5
(0.06 pg), dimethylarginine dimethylaminohydrolase 1 (0.063
pg), and mitochondrial fusion protein 1 (0.076 pg). Support-
ing Information Table 1 reports the protein scores, number
of peptides, sequence coverage, estimated abundance, and
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Table 1. Differences in protein abundance between HCR and LCR visceral adipose tissue
Description Database Estimated protein abundance (pg) Percentage p value
ID
HCR LCR
difference
Adipogenesis/adipocyte differentiation
Protein S100-B P04631 0.37 ± 0.28 1.71 ± 0.57 + 431% 0.0001
Cathepsin D P24268 0.50 ± 0.09 0.93 ± 0.21 + 88% 0.0010
Carbonic anhydrase 1 B0BNN3 1.42 ± 0.37 2.05 ± 0.52 + 44% 0.0025
Glycerol-3-phosphate dehydrogenase
[NAD+], cytosolic
O35077 6.42 ± 1.34 9.03 ± 0.98 + 41% 0.0000
Aldehyde dehydrogenase, mitochondrial P11884 5.71 ± 0.56 6.87 ± 1.20 + 20% 0.0054
Long chain fatty acid CoA-ligase 1 P18163 14.07 ± 1.25 16.65 ± 0.92 + 18% 0.0002
Sulfotransferase 1A1 P17988 0.31 ± 0.06 0.15 ± 0.06 −89% 0.0003
Galectin-1 P11762 7.92 ± 0.64 6.91 ± 0.92 −15% 0.0049
Antioxidant/stress response
Mitogen-activated protein kinase 3 P21708 0.23 ± 0.06 0.35 ± 0.08 +43% 0.0047
78 kDa glucose-regulated protein P06761 4.16 ± 0.35 4.90 ± 0.53 +18% 0.0017
Heat shock protein beta-1 P42930 2.70 ± 0.42 1.82 ± 0.20 −48% 0.0000
Glutathione S-transferase P P04906 2.14 ± 0.42 1.51 ± 0.25 −42% 0.0002
Peroxiredoxin-6 O35244 1.65 ± 0.42 1.20 ± 0.25 −38% 0.0053
Superoxide dismutase [Cu-Zn] P07632 2.92 ± 0.45 1.20 ± 0.25 −30% 0.0003
Selenium-binding protein 1 Q8VIF7 2.90 ± 0.28 2.23 ± 0.17 −23% 0.0003
Immune cell function
Ig gamma-2B chain C region P20761 0.19 ± 0.08 0.89 ± 0.38 + 362% 0.0005
Ig kappa chain C region, B allele P01835 1.24 ± 0.51 2.60 ± 0.93 +110% 0.0044
Class I histocompatability antigen,
Non-RT1.A alpha
P15978 0.20 ± 0.08 0.32 ± 0.05 +62% 0.0023
Ig gamma-2A chain C region P20760 3.15 ± 0.90 4.91 ± 1.72 +56% 0.0039
Energy metabolism
Triosephosphate isomerase P48500 2.45 ± 0.35 3.16 ± 0.66 +29% 0.0049
Glyceraldehyde-3-phosphate
dehydrogenase
P04797 4.46 ± 0.55 5.28 ± 0.76 +18% 0.0058
Phosphoglycerate kinase P16617 2.63 ± 0.21 2.06 ± 0.27 −27% 0.0000
ADP/ATP translocase 1 Q05962 0.62 ± 0.05 0.48 ± 0.04 −28% 0.0021
Miscellaneous
T-kininogen 2 P08932 0.26 ± 0.03 0.38 ± 0.10 +47% 0.0070
Hemopexin P20059 7.34 ± 1.22 10.14 ± 0.95 +38% 0.0000
Serotransferrin P12346 26.24 ± 2.41 31.0 ± 3.37 +18% 0.0015
Ras-related protein Rab-11A P62494 0.40 ± 0.06 0.29 ± 0.04 −35% 0.0068
Purine nucleoside phosphorylase P85973 1.12 ± 0.09 0.83 ± 0.19 −34% 0.0003
Annexin A3 P14669 1.97 ± 0.27 1.60 ± 0.23 −23% 0.0028
Profilin-1 P62963 2.60 ± 0.35 2.19 ± 0.16 −18% 0.0026
Proteins under each subheading are ranked (greatest first) by relative differences (percentage difference) in LCR compared to HCR. Each
of the listed proteins exhibited significant (p<0.05) differences in abundance at an FDR of <10%. Description and database ID relate to
the protein name and accession number identified from HDMSE searches of the UniProt Rattus database performed in ProteinLynx Global
Server. Protein abundance (pg) on column was estimated relative to a ‘spiked’ yeast alcohol dehydrogenase digest.
differences in relative abundance between HCR and LCR for
the 448 proteins included in the statistical analysis.
Gene ontology analysis performed using DAVID found
the majority of proteins were of cytosolic (130 proteins) or
mitochondrial (128 proteins) origin. Prominent Biological
Processes included: alcohol catabolic process (30 proteins)
and glucose catabolic process (27 proteins). While the main
molecular functions related to GTP binding (50 proteins)
and nucleotide binding (172 proteins). When clustered ac-
cording to associations in the Kyoto Encyclopaedia of Genes
and Genomes (KEGG; http://www.genome.jp/kegg/), the
top ranking pathway was Glycolysis/gluconeogensis, which
encompassed 27 proteins representing 6.2% of the docu-
mented pathway. Other prominent pathways included fatty
acid metabolism (18 proteins) and glutathione metabolism
(19 proteins).
A total of 79 statistically significant (p<0.05) differences
in protein abundance were detected between HCR and LCR
adipose samples and after correction (q-value) for multiple
testing, 30 significant differences exhibited a false discovery
rate of less than 10% (q<0.1). Table 1 reports the protein iden-
tity and differences in abundance between HCR and LCR for
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Figure 1. Association network drawn from proteins that differed in abundance in HCR and LCR visceral adipose tissue. Proteins that
exhibited statistically significant (p<0.05, FDR <10%) differences in abundance (Table 1) were imported to the statistical tool for the re-
trieval of interacting genes/proteins (STRING). Nodes represent individual proteins annotated with common gene names: 678 757, Ig
kappa chain C region, B allele; Acsl1, long-chain fatty acid Co-A ligase 1; Aldh2, aldehyde dehydrogenase 2; Ctsd, cathepsin D; Gapdh,
glyceraldehyde-3-phosphate dehydrogenase; Gpd1, glycerol-3-phosphate dehydrogenase [NAD+] cytosolic; Hpx, Hemopexin; Hspa5,
78-kDa glucose-regulated protein; Hspb1, heat shock protein beta-1; IgG-2a, Ig gamma-2B Chain C region; Kng1|1, T-kininogen 2; Mapk3,
mitogen-activate protein kinase 3; Pfn1, profilin-1; Pgk1, phosphoglycerate kinase; Prdx6, peroxiredoxin-6; Selenbp1, selenium binding
protein-1; Slc25a4, ADP/ATP translocase 1; Sod1, superoxide dismutase [Cu-Zn]; Tf, serotransferrin; Tpi1, triosephosphate isomerase.
Vectors between nodes are color coded to represent different levels of information, including: evidence of co-expression (black), protein–
protein interaction (pink), concurrence in databases such as the Kyoto Encyclopaedia of Genes and Genomes (KEGG; blue) or PubMed
abstracts (green). A medium confidence cut-off was used and no additional interactions were added.
the top-ranked (p<0.05, FDR <10%) 30 proteins. A number
of the proteins that differed between HCR and LCR have
previously been associated with adipogenesis or adipocyte
differentiation in vitro. Proteins associated with antioxidant
or cellular stress response, immune cell function, and en-
ergy metabolism were other prominent features. Among the
most abundant of the differentially expressed proteins were
serotransferrin (29 pg on column) and long-chain fatty acid
CoA-ligase 1 (15 pg on column) while the least abundant
(>0.5 pg on column) differentially expressed proteins de-
tected included sulfotransferase 1A1, IgG2B C-chain, and
mitogen-activated protein kinase 3.
The search tool for the retrieval of interacting
genes/proteins (STRING) was used to construct a graph-
ical network (Fig. 1) based on evidence of co-expression,
protein–protein interaction, co-occurrence in KEGG path-
ways, and literature mining. The network constructed from
15 proteins that matched to the STRING DB and were
significantly (p<0.05, FDR <10%) more abundant in LCR
included protein–protein interactions between Mapk3 and
Hspa5, Aldh2, TF, Acsl1, Tpi1, and Gapdh. Protein–protein
interactions were also found between Aldh2 and Tpi1, and
for Acsl1 and Hspa5. Co-expression was reported between Tf
and Hpx, Tpi1 and Gapdh, Acsl1 and Ctsd, Mapk3 and Ctsd,
Igg-2a and 678757 (IgG-2B chain C region). In addition, links
were drawn based on co-occurrence in KEGG pathways and
text mining.
Fewer interactions were found within the 13 proteins that
were significantly (p<0.05, FDR <10%) more abundant in
HCR. The only notable evidence being co-expression of per-
oxiredoxin 6 and selenium-binding protein in one proteomic
profiling experiment.
4 Discussion
Despite a ninefold difference in innate running capacity,
there was no difference in the abundance of mitochondrial
proteins between HCR and LCR visceral adipose tissue.
Instead, our nontargeted analysis highlighted significant
differences in putative adipokines and proteins involved
in adipogenesis, oxidative stress, and inflammation. Our
label-free profiling encompassed 448 proteins and detected
30 statistically significant (p<0.05, FDR<10%) differences in
protein abundance. The majority of these proteins have pre-
viously been detected in proteomic analyses of adipocytes iso-
lated from human [22] or mouse [23] adipose tissues. Notable
exceptions include IgG and MHC proteins that were signifi-
cantly more abundant in LCR. Thismay indicate greater infil-
tration of inflammatory cells in LCR visceral adipose tissue.
The role of macrophages and T lymphocytes in adipose tis-
sue inflammation has long been recognized, whereas the role
of B lymphocytes has more recently come to light. Herein we
report the pro-inflammatory IgG-2BChainC isotope,which is
produced by B cells was 362%more abundant in LCR visceral
adipose tissue. The accumulation of B cells in adipose tissue
is an early event in diet-induced obesity that precedes T-cell
infiltration, the onset of insulin resistance, and macrophage
accumulation [24]. During obesity, B cells within adipose tis-
sue may instigate inflammation both by presenting antigen
viaMHC I to activate CD8+ (i.e. cytotoxic) T cells and through
the production of pro-inflammatory IgG2c [25].When studied
in vitro, B cells modulate T-cell release of pro-inflammatory
cytokines [26] and our data suggest low aerobic capac-
ity may also be associated with similar pro-inflammatory
interactions.
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ER stress associated with adipocyte enlargement is an-
other early mechanism associated with inflammatory re-
sponses such as the production of TNF- and infiltration
of macrophages to adipose tissue [27]. The 78 kDa glucose-
regulated protein (GRP-78, also known as BiP) was more
abundant in LCR and is a recognized marker of ER stress
that is induced by the unfolded protein response associated
with adipogenesis [28] and pharmacological agents such as
tunicamycin [29]. ER stress can occur due to the accumula-
tion of unfolded proteins caused by oxidative stress-related
protein damage. Accordingly, antioxidant enzymes, includ-
ing superoxide dismutase, peroxiredoxin 6, and glutathione
S-transferase were significantly less abundant in LCR. This
finding is consistent with the greater oxidative stress re-
ported in the kidneys [30], liver [21], skeletal muscle [31],
and heart [32] of LCR rats and further highlights oxidative
stress as a common process associated with low aerobic ca-
pacity. Herein nontargeted proteomics also detected a signif-
icantly greater (43%) abundance of mitogen-activated protein
kinase 3 (ERK1), which is commonly activated in adipocytes
exposed to pharmacologically induced ER stress [33] or in-
flammatory cytokines [34]. This finding adds weight to the
hypothesis that low innate aerobic capacity per se is suf-
ficient to predispose animals to obesity and adipose tissue
inflammation.
Adipose tissue is recognized as an endocrine organ that
secretes adipokines that affect tissues such as the hypothala-
mus, liver, and skeletal muscle. In addition to well-described
adipokines, such as leptin, proteomic studies (e.g. [35–37])
point to a broad array of putative adipokines that may be
released or secreted from adipocytes in vitro. In addition,
comprehensive mining of the 3T3-L1 adipocyte proteome by
Adachi et al. [23] highlighted 554 adipocyte proteins with sig-
nal peptides for the ER-Gologi export pathway. Five of the
proteins that differed in abundance between HCR and LCR
(Table 1) either have a signal peptide or have been reported
as secreted from adipocytes in vitro. Putative adipokines
that were more abundant in LCR visceral adipose tissue in-
clude S100-B, cathepsinD, serotransferrin, andGRP-78/ BiP,
whereas sulfotransferase 1A1 and galectin-1 weremore abun-
dant in HCR. The majority of the above proteins have been
associated with obesity, metabolic syndrome, or type 2 di-
abetes. For example, mRNA expression of cathepsin D is
upregulated in adipose tissue of mice exposed to a high-fat
diet and in obese humans, and studies in vitro suggest dif-
ferentiation of pre-adipocytes is dependent upon cathepsin
D expression [38]. Sulfotransferase 1A1 does not have a sig-
nal peptide for the golgi excretory pathway but has previously
been highlighted as a gene associated with T2DMby genome-
wide scans. Indeed, sulfotransferase 1A1 mRNA expression
is downregulated in response to HFD alongside other can-
didates close to genetic loci for obesity [39]. Galectin-1 also
lacks a signal peptide but is reported to be more abundant in
plasma of T2DM patients, which contrasts with our findings.
However, galectin-1 is highly expressed in skeletalmuscle [40]
and exposure of skeletal muscle to glucose increases galectin-
1 [41]. Thus, the elevations in plasma galectin-1 in T2DM pa-
tients may primarily arise from skeletal muscle rather than
adipose tissue.
S100-B does not have a canonical signal peptide but is rela-
tively abundant in adipose tissue (HCR0.37± 0.28; LCR1.7±
0.57 pg on column) and is widely documented as a secreted
protein. Circulating levels of S100-B correlate positively with
BMI [42] and visceral obesity [43] but this is not evident in
all studies (e.g [44]) and because S100-B is also released from
brain astrocytes it is also regarded as a biomarker of blood–
brain barrier permeability. Nonetheless, the current finding
that an estimated 100% difference in adipose tissue mass
is associated with a >400% increase in S100-B abundance
supports the role of this protein as a sensitive biomarker
of adiposity. Furthermore, S100-B has recently been impli-
cated mechanistically in the interaction between adipocytes
and macrophages in vitro. Fujiya et al. [45] report S100-B
stimulates the release of TNF- from RAW macrophages
and primary monocytes, and upregulates markers of M1
macrophages. Correspondingly, TNF- augments S100-B se-
cretion from 3T3-L1 adipocytes creating a reciprocal interac-
tion that may amplify the inflammatory response of adipose
tissues in obese subjects.
When fed a high-fat diet (HFD), LCR gain significantly
more weight than HCR despite the fact that HCR con-
sume a greater amount of calories relative to body mass
[2] In the current work, many of the proteins that were
more abundant in LCR visceral adipose tissue are also rec-
ognized markers of adipocyte differentiation. For example,
the greater abundances of glycerol-3-phosphate dehydroge-
nase and long-chain fatty acid CoA ligase may contribute
to the relatively greater propensity for obesity in LCR rats.
Our nontargeted analysis was able to detect important adi-
pose tissue proteins highlighted through hypothesis-led re-
search, including lipoprotein lipase, fatty acid translocase,
adipose fatty acid binding protein, adipose triglyceride lipase,
hormone-sensitive lipase, fatty acid synthase, perilipin 1 and
retinol binding protein 4. However, the abundances of these
proteins were not significantly different between HCR and
LCR visceral adipose tissue. Interestingly, LCR did exhibit
lesser abundance (p<0.05, FDR >10%) of comparative gene
identification-58, which enhances the lipase activity of adi-
pose triglyceride lipase [46] and has previously been reported
to be less abundant in LCR adipose tissue [9].
While adiposity is a correlated trait of selection on running
capacity, it is not associated with overt differences in the pro-
file of enzymes of aerobic metabolism in adipose tissue. In-
stead, our nontargeted proteomic analysis has revealed LCR
visceral adipose tissue has relatively poor defences against
oxidative stress and exhibits markers of adipocyte differen-
tiation, ER stress, and inflammation. Moreover, several pu-
tative adipokines differed in abundance between HCR and
LCR. In particular S100-B protein, which has recently been
mechanistically linked in adipose tissue inflammation was
431% more abundant in LCR and may represent candidate
biomarker of clinical relevance.
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